China's independent research and development of brain pacemaker to break the monopoly of imported products
-
Last Update: 2020-06-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Business Agency, April 7 - Tsinghua University multidisciplinary cross-research team after 10 years of successful development of a series of brain pacemaker, in 2013 to obtain a product registration certificate, breaking the exclusive monopoly of imported productsBy the end of March 2014, Tsinghua Brain Pacemaker had completed nearly 600 implantson April 11th, the world Parkinson's disease day is coming, "the third Tsinghua Brain Pacemaker Forum - Parkinson's Day Care Activities" large-scale public welfare activities held in Tsinghua University on the 6thThe event invited more than 10 People with Parkinson's disease who had been implanted with a Tsinghua brain pacemaker to the scene, where they performed a chorusProfessor Li Luming, director of the National Engineering Laboratory of Neuroregulation Technology at Tsinghua University, said that according to statistics, the number of people with Parkinson's disease in China reached 2.5 millionThe treatment of Parkinson's disease by a brain pacemaker is an important achievement in brain science research at the end of the 20th century, it implants electrodes into specific parts of the brain, achieves therapeutic effect through chronic electrical stimulation, is the preferred therapy for the surgical treatment of Parkinson's disease, and more than 100,000 patients worldwide have been implanted with a brain pacemaker, as an active implant class of high-endmedical device, brain pacemaker has a high technical and engineering development difficultiesTsinghua University brings together a multi-disciplinary research team to apply manned space technology to the development of a pacemakerBy the end of March 2014, Tsinghua Brain Pacemakerhad had completed nearly 600 implants in 27 provinces and Singaporeit is reported that the rechargeable version of the Tsinghua Brain Pacemaker completed a one-year follow-up of 53 clinical trials in 2013 and submitted a registration application, which is expected to be listed this yearRechargeable computer pacemaker has the advantage of long life (10 years), low annual treatment cost, compared to the non-chargeable computer pacemaker 3 to 5 years need to re-replace the pulse generator, but also reduce the risk of frequent surgery
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.